One stock that might be an intriguing choice for investors right now is Albireo Pharma, Inc. ALBO. This is because this security in the Medical - Biomedical and Genetics space is seeing solid earnings ...
– Appointment strengthens leadership team as the Company readies for potential global odevixibat launch and progresses multiple clinical development programs – – Deep experience spanning drug ...
Ipsen (OTCPK:IPSEY) (OTCPK:IPSEF) is acquiring Albireo (NASDAQ:ALBO) in deal worth about $952M plus one contingent value right (CVR) per share to bolster its rare disease portfolio with treatments for ...
Ipsen’s near-$1 billion deal for Albireo was among a trio of biopharma acquisitions that opened this year’s J.P. Morgan Healthcare Conference. But Ipsen only got a chance to bid thanks to a sudden ...
-Highly statistically significant reductions in both pruritus and serum bile acids- -Well tolerated with very low incidence of diarrhea- -Similar efficacy in children with PFIC1 or PFIC2- -Pivotal ...
BOSTON, June 08, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced the presentation of seven ...
After Ipsen made a splash at this year's J.P. Morgan Healthcare Conference by scooping up liver disease specialist Albireo Pharma, the centerpiece of the buyout, Bylvay, has won a coveted label ...
BOSTON, June 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced it has ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Albireo enrolled the first patient in a phase 3 clinical ...
The regulator on Tuesday approved odevixibat, an Albireo Pharma drug developed to treat severe itching, or pruritus, in patients who have the liver disorder progressive familial intrahepatic ...
Albireo Energy Earns Great Place To Work Certification™ for Eighth Consecutive Year Albireo Energy, a leading independent building controls and energy services provider and Huron Capital portfolio ...